BIOSYSEN (01355.HK) plans to conduct a rights issue on the basis of \"2 for 1\", with estimated net proceeds of HKD 39 million

BIOSYSEN (01355.HK) announced on Jun 24, 2026 that the company proposes to issue up to 596.53 million shares through a rights issue, on the basis of "2 for 1" at a price of HK cents 6.8 per rights issue share. The maximum total proceeds from the rights issue are estimated to be about HKD 40 million, with net proceeds of approximately HKD 39 million.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.